Rankings
▼
Calendar
ARCT FY 2021 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena
ARCT
Arcturus Therapeutics Holdings Inc.
$210M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$12M
+29.6% YoY
Gross Profit
$12M
100.0% margin
Operating Income
-$203M
-1641.3% margin
Net Income
-$204M
-1648.0% margin
EPS (Diluted)
$-7.74
Cash Flow
Operating Cash Flow
-$135M
Free Cash Flow
-$138M
Stock-Based Comp.
$29M
Balance Sheet
Total Assets
$393M
Total Liabilities
$165M
Stockholders' Equity
$228M
Cash & Equivalents
$370M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$12M
$10M
+29.6%
Gross Profit
$12M
-$46M
+126.6%
Operating Income
-$203M
-$72M
-183.6%
Net Income
-$204M
-$72M
-182.3%
← Q4 2020
All Quarters
Q1 2021 →